In January 2024, the Company granted 4,590 shares of restricted stock units to employees and directors. One third of these shares vested on March 31, 2024 and one third vested on January 1, 2025. The final 1,522 units with a weighted average grant date fair value of $76.45 vested on January 1, 2026.

The fair values of the respective vesting dates of RSUs were approximately $6,255 and $5,096 for the six months ended June 30, 2026 and 2025, respectively.


	Shares			Weighted Average Exercise Price
Stock Options Outstanding at January 1, 2026		621,184		$	2.15
Granted		-			-
Exercised		(38,665	)		1.63
Forfeited / Expired		-			-
Stock Options Outstanding at June 30, 2026		582,519		$	2.18

The Company had a total of 205,450 unvested options as of June 30, 2026 that are expected to vest in the future. Total unrecognized share based compensation expense from the remaining unvested options as of June 30, 2026 was approximately $232,600 and is expected to be recognized in earnings over a weighted average period of 0.9 years. The Company had 377,069 exercisable options as of June 30, 2026.

The weighted average remaining contractual term for all options outstanding at June, 2026, was 8.8 years and the aggregate intrinsic value (difference in exercise price and closing price at that date) was approximately $1.6 million. The weighted average remaining contractual term for options vested and exercisable at June 30, 2026, was 8.8 years and the aggregate intrinsic value was approximately $1.1 million.

The Company utilized the simplified method for estimating the stock options granted as the Company has experienced significant changes in its business and the historical data may not provide a reasonable basis upon which to estimate expected term.